[1]陈金 王云峰 赵瑞瑞 郑艳霞 张颖.清肺化痰汤治疗支气管肺炎的有效性[J].陕西中医药大学学报,2023,(05):094-98.[doi:10.13424/j.cnki.jsctcm.2023.05.015]
 CHEN Jin WANG Yunfeng ZHAO RuiruiZHENG YanxiaZHANG Ying.Effectiveness of Qingfei Huatan Decoction in Treating Bronchopneumonia[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(05):094-98.[doi:10.13424/j.cnki.jsctcm.2023.05.015]
点击复制

清肺化痰汤治疗支气管肺炎的有效性
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2023年05期
页码:
094-98
栏目:
临床研究
出版日期:
2023-10-14

文章信息/Info

Title:
Effectiveness of Qingfei Huatan Decoction in Treating Bronchopneumonia
文章编号:
20961340(2023)05-0094-05
作者:
陈金1 王云峰2 赵瑞瑞1 郑艳霞1 张颖1
1.榆林市中医医院,陕西 榆林 719000;
2.神木市医院,陕西 榆林 719300
Author(s):
CHEN Jin1 WANG Yunfeng2 ZHAO Ruirui1ZHENG Yanxia1ZHANG Ying1
1.Yulin Traditional Chinese Medicine Hospital,Shaanxi Yulin 719000,China ;
2.Shenmu City Hospital,Shaanxi Yulin 719300,China
关键词:
关键词:清肺化痰汤氧化应激肺功能支气管肺炎随机对照炎性因子
Keywords:
Key words: Qingfei Huatan decoctionOxidative stressLung functionBronchopneumoniaRandomized controlInflammatory factors
分类号:
R256.1
DOI:
10.13424/j.cnki.jsctcm.2023.05.015
文献标志码:
A
摘要:
摘 要:目的 探究清肺化痰汤对支气管肺炎患者肺功能、氧化应激指标和炎性因子的影响。方法 收集2021年4月—2022年5月榆林市中医医院收治的支气管肺炎患者80例,随机分为对照组(40例,常规西药治疗),治疗组(40例,常规西药+清肺化痰汤治疗),评估临床疗效,测量治疗前及治疗后患者血清炎性因子、肺功能、氧化应激指标,记录不良反应。结果 总有效率对比,治疗组高于对照组(P<0.05);治疗组治疗后血清白介素6(IL6)、C反应蛋白(CRP)水平均显著低于对照组(P<0.05);治疗后治疗组第1秒用力呼气容积(FEV1)、用力肺活量(FVC)显著高于对照组(P<0.05);治疗后治疗组血清丙二醛(MDA)水平显著低于对照组,超氧化物歧化酶(SOD)水平高于对照组(P<0.05);组间不良反应发生率无显著差异(P>0.05)。结论 给予支气管肺炎患者清肺化痰汤治疗可下调血清炎性因子水平,减轻氧化应激损伤,改善肺功能,且未见不良反应增多表现。
Abstract:
Abstract: Objective To explore the effects of Qingfei Huatan decoction on lung function,oxidative stress indicators,and inflammatory factors in patients with bronchopneumonia.Methods A total of 80 patients with bronchopneumonia admitted to our hospital from April 2021 to May 2022 were collected and randomly divided into control group (40 cases,treated with conventional Western medicine) and treatment group (40 cases,treated with conventional Western medicine and Qingfei Huatan decoction).Clinical efficacy was evaluated,serum inflammatory factors,lung function,oxidative stress indicators were measured before and after treatment,and adverse reactions were recorded.Results The total effective rate of the treatment group was higher than that of the control group (P<0.05);After treatment,the levels of serum interleukin-6 (IL-6) and C-reactive protein (CRP) in the treatment group were significantly lower than those in the control group (P<0.05);After treatment,the first second forced expiratory volume (FEV1) and forced vital capacity (FVC) of the treatment group were significantly higher than those of the control group (P<0.05);After treatment,the serum levels of malondialdehyde (MDA) in the treatment group were significantly lower than those in the control group,while the levels of superoxide dismutase (SOD) were higher than those in the control group (P<0.05);There was no significant difference in the incidence of adverse reactions between groups (P>0.05).Conclusion Treating patients with bronchopneumonia with Qingfei Huatan decoction can downregulate serum inflammatory factor levels,alleviate oxidative stress damage,improve lung function,and show no increase in adverse reactions.

参考文献/References:

[1]Song HX,Lei T,Wu F,et al.Two new luminescent Cd(II) coordination polymers and their application values on children bronchopneumonia[J].Arabian Journal of Chemistry,2021,14(8):103297.
[2]邓志考,苏芝兰,曾成.溴己新联合阿奇霉素治疗小儿支气管肺炎的效果及对血清C反应蛋白、降钙素原的影响[J].中国医学创新,2022,19(8):1-5.
[3]关丽娜,骆小平,赵彩虹.布地奈德联合沙丁胺醇治疗支气管肺炎患儿临床疗效分析[J].临床军医杂志,2021,49(7):731-733,737.
[4]陶媛媛,陈鹏,张金兰.小青龙汤加减治疗小儿支气管肺炎疗效观察[J].吉林中医药,2022,42(2):184-186.
[5]葛燕萍,王绍谦,孔静.清肺化痰汤对重症肺炎(痰热壅肺证)患者中医证候积分、免疫功能及炎性因子的影响[J].中国中医急症,2022,31(8):1213-1216.
[6]中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中国实用乡村医生杂志,2013,20(2):11-15.
[7]Duan X,Wang H,Wu J,et al.Comparative Efficacy of Chinese Herbal Injections for Treating Pediatric Bronchopneumonia:A Bayesian Network Meta-Analysis of Randomized Controlled Trials[J].Evidencebased Complementary and Alternative Medicine,2020(4):1-12.
[8]李俊,周杰,陈丽霞,等.干扰素联合沙丁胺醇雾化配合氧疗在儿童支气管肺炎中的应用[J].中国临床药理学杂志,2022,38(16):1843-1846.
[9]罗玲玲,滕承志,李晓笑,等.阿奇霉素联合盐酸氨溴索治疗小儿支原体肺炎合并急性支气管炎的临床研究[J].中国临床药理学与治疗学,2017,22(11):1278-1282.
[10]李艳华,史鸽,史笑敏.脾多肽注射液联合布地奈德雾化吸入治疗支气管肺炎的效果及对免疫功能的影响[J].广东医学,2020,41(23):2398-2401.
[11]王书玲,侯江红,陈团营,等.柴葛芩连汤联合常规治疗对湿热闭肺型小儿支气管肺炎患者的临床疗效[J].中成药,2020,42(1):85-88.
[12]龚海蓉,韩爱民.麻杏石甘汤加减联合布地奈德对小儿支气管肺炎临床疗效、炎性因子的影响[J].湖北中医药大学学报,2020,22(6):67-69.
[13]高占华,郭建恩,刘利蕊,等.自拟清肺化痰汤对支气管肺炎患者临床症状及炎性因子的影响[J].中药材,2016,39(10):2373-2375.
[14]丁倩云,马双成,许风国,等.桑白皮的化学成分、药理及质量控制研究进展[J].药物分析杂志,2021,41(7):1114-1124.
[15]杨福双,曹方,孔一卜,等.基于网络药理学桑白皮地骨皮药对治疗儿童肺炎的作用机制研究[J].海南医学院学报,2022,28(4):294-302.
[16]孙禹,梁伟.浙贝母的化学成分、药理作用及临床应用研究进展[J].特产研究,2022,44(1):87-92.
[17]崔明超,王翰华,陈少军.基于网络药理学及分子对接的浙贝母花枇杷花药对止咳化痰作用机制研究[J].天然产物研究与开发,2021,33(2):282-290,321.
[18]赵玉升,胡杰,吴佳姝,等.苦杏仁炮制方法及药理作用研究进展[J].中医药导报,2021,27(3):175-180.
[19]夏其乐,王涛,陆胜民,等.苦杏仁苷的分析、提取纯化及药理作用研究进展[J].食品科学,2013,34(21):403-407.
[20]刘宪河.支气管肺炎患儿血清hs-CRP、IL-6和TNF-α水平变化及临床意义[J].河北医药,2019,41(1):99-102.
[21]李光超,金瑄.杏贝止咳祛痰口服液联合盐酸氨溴索口服液治疗小儿支气管肺炎的临床研究[J].宁夏医科大学学报,2017,39(11):1344-1347.
[22]卓小玉,陈晶,田明,等.麻黄的化学成分与药理作用研究进展[J].中医药信息,2021,38(2):80-83.
[23]李春连,王利玲,王远照,等.宣氏小儿清肺糖浆联合西药治疗小儿支气管肺炎痰热闭肺证临床研究[J].陕西中医药大学学报,2017,40(1):70-72.
[24]柏发蕊,许栋,姜松鹿.热毒宁注射液治疗成人支气管肺炎40例[J].西部中医药,2019,32(2):98-100.
[25]韩晓晓,赵迪,刘学芳,等.基于网络药理学和分子对接技术探讨黄芪-紫苏子配伍治疗慢性阻塞性肺疾病的作用机制[J].世界科学技术-中医药现代化,2021,23(9):3147-3159.

相似文献/References:

[1]都梦帆 胥冰 郭东艳 史亚军 张小飞 程江雪 向汝.基于Aβ蛋白的阿尔兹海默症的中医药治疗研究进展[J].陕西中医药大学学报,2022,(02):146.[doi:10.13424/j.cnki.jsctcm.2022.02.032]

备注/Memo

备注/Memo:
基金项目:榆林市科技计划项目(YF-2020-068)
更新日期/Last Update: 2023-09-22